Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2008-6-24
pubmed:abstractText
Paget's disease (PD) of bone is characterized by increased activity of large abnormal osteoclasts (OCLs) which contain paramyxoviral nuclear and cytoplasmic inclusions. MVNP gene expression has been shown to induce pagetic phenotype in OCLs. We previously characterized the osteoclast inhibitory peptide-1 (OIP-1/hSca) which inhibits OCL formation/bone resorption. OIP-1 is a glycophosphatidylinositol (GPI)-linked membrane protein containing a 79 amino acid extra cellular peptide and a 32 amino acid carboxy terminal GPI-linked peptide (c-peptide) which is critical for OCL inhibition. In this study, we demonstrate that OIP-1 c-peptide significantly decreased (43%) osteoclast differentiation of peripheral blood mononuclear cells from patients with PD. Also, OIP-1 treatment to normal human bone marrow mononuclear cells transduced with the MVNP inhibited (41%) osteoclast precursor (CFU-GM) growth in methyl-cellulose cultures. We further tested if OIP-1 overexpression in the OCL lineage in transgenic mice inhibits MVNP stimulated OCL formation. MVNP transduction and RANKL stimulation of OIP-1 mouse bone marrow cells showed a significant decrease (43%) in OCL formation and inhibition (38%) of bone resorption area compared to wild-type mice. Western blot analysis identified that OIP-1 decreased (3.5-fold) MVNP induced TRAF2 expression during OCL differentiation. MVNP or OIP-1 expression did not affect TRAF6 levels. Furthermore, OIP-1 expression resulted in a significant inhibition of MVNP stimulated ASK1, Rac1, c-Fos, p-JNK, and NFATc1 expression during OCL differentiation. These results suggest that OIP-1 inhibits MVNP induced pagetic OCL formation/activity through suppression of RANK signaling. Thus, OIP-1 may have therapeutic utility against excess bone resorption in patients with PD.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18348201-10712432, http://linkedlifedata.com/resource/pubmed/commentcorrection/18348201-10862799, http://linkedlifedata.com/resource/pubmed/commentcorrection/18348201-10962354, http://linkedlifedata.com/resource/pubmed/commentcorrection/18348201-11127197, http://linkedlifedata.com/resource/pubmed/commentcorrection/18348201-11416009, http://linkedlifedata.com/resource/pubmed/commentcorrection/18348201-11771657, http://linkedlifedata.com/resource/pubmed/commentcorrection/18348201-11937650, http://linkedlifedata.com/resource/pubmed/commentcorrection/18348201-11992264, http://linkedlifedata.com/resource/pubmed/commentcorrection/18348201-12619930, http://linkedlifedata.com/resource/pubmed/commentcorrection/18348201-12732718, http://linkedlifedata.com/resource/pubmed/commentcorrection/18348201-14595764, http://linkedlifedata.com/resource/pubmed/commentcorrection/18348201-14960283, http://linkedlifedata.com/resource/pubmed/commentcorrection/18348201-15176999, http://linkedlifedata.com/resource/pubmed/commentcorrection/18348201-15314684, http://linkedlifedata.com/resource/pubmed/commentcorrection/18348201-15493999, http://linkedlifedata.com/resource/pubmed/commentcorrection/18348201-15690073, http://linkedlifedata.com/resource/pubmed/commentcorrection/18348201-16135834, http://linkedlifedata.com/resource/pubmed/commentcorrection/18348201-16220542, http://linkedlifedata.com/resource/pubmed/commentcorrection/18348201-16429324, http://linkedlifedata.com/resource/pubmed/commentcorrection/18348201-16491293, http://linkedlifedata.com/resource/pubmed/commentcorrection/18348201-17135582, http://linkedlifedata.com/resource/pubmed/commentcorrection/18348201-17173138, http://linkedlifedata.com/resource/pubmed/commentcorrection/18348201-17187080, http://linkedlifedata.com/resource/pubmed/commentcorrection/18348201-1719635, http://linkedlifedata.com/resource/pubmed/commentcorrection/18348201-17380158, http://linkedlifedata.com/resource/pubmed/commentcorrection/18348201-17940999, http://linkedlifedata.com/resource/pubmed/commentcorrection/18348201-7691583, http://linkedlifedata.com/resource/pubmed/commentcorrection/18348201-8650192, http://linkedlifedata.com/resource/pubmed/commentcorrection/18348201-8915767, http://linkedlifedata.com/resource/pubmed/commentcorrection/18348201-9325440, http://linkedlifedata.com/resource/pubmed/commentcorrection/18348201-9774977, http://linkedlifedata.com/resource/pubmed/commentcorrection/18348201-9831565
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1097-4644
pubmed:author
pubmed:copyrightInfo
2008 Wiley-Liss, Inc.
pubmed:issnType
Electronic
pubmed:day
1
pubmed:volume
104
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1500-8
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:18348201-Adaptor Proteins, Signal Transducing, pubmed-meshheading:18348201-Animals, pubmed-meshheading:18348201-Bone Resorption, pubmed-meshheading:18348201-Cell Differentiation, pubmed-meshheading:18348201-Gene Expression Regulation, pubmed-meshheading:18348201-Humans, pubmed-meshheading:18348201-LIM Domain Proteins, pubmed-meshheading:18348201-Leukocytes, Mononuclear, pubmed-meshheading:18348201-Measles virus, pubmed-meshheading:18348201-Mice, pubmed-meshheading:18348201-Mice, Transgenic, pubmed-meshheading:18348201-Nucleocapsid Proteins, pubmed-meshheading:18348201-Osteitis Deformans, pubmed-meshheading:18348201-Osteoclasts, pubmed-meshheading:18348201-RANK Ligand, pubmed-meshheading:18348201-TNF Receptor-Associated Factor 2, pubmed-meshheading:18348201-Transcription Factors, pubmed-meshheading:18348201-Transduction, Genetic
pubmed:year
2008
pubmed:articleTitle
Osteoclast inhibitory peptide-1 (OIP-1) inhibits measles virus nucleocapsid protein stimulated osteoclast formation/activity.
pubmed:affiliation
Charles P. Darby Children's Research Institute, Medical University of South Carolina, Charleston, South Carolina 29425, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, Non-P.H.S., Research Support, N.I.H., Extramural